r e s o u r c e
In homeostasis, blood production depends on a highly coordinated hierarchy of hematopoietic cells. At the apex of the hierarchy are hematopoietic stem cells (HSCs), which are capable of self-renewal, have multilineage potential and are responsible for generating all the lineages of hematopoietic cells in the blood. The self-renewal ability and multipotentiality of HSCs are gradually lost as cells progress through various multilineage, 'oligolineage' and 'unilineage' intermediates and eventually acquire erythroid, myeloid or lymphoid identity. Understanding how the genomic information in HSCs 'translates' into such complex differentiation programs is crucial for the development of new approaches in regenerative medicine and better cancer therapeutics.
At the molecular level, targeted functional studies of single or paired transcription factors have identified a relatively small number of key transcription factors that drive the differentiation of progenitor cells by directing the sequential establishment of transcriptional programs essential for terminal differentiation 1 . Complex transcriptional networks integrated around the bimodal 'switch' of the transcription factors GATA-1 and PU.1 represent a paradigm for myeloid-versus-erythroid lineage specification 2 . In contrast, differentiation into lymphoid lineages follows a more linear network 'architecture' . The establishment of lymphoid identity requires successive and obligatory activation of the transcription factors E2A, Ebf1 and, finally, Pax5 in distinct progenitor populations 3, 4 . However, a clear genome-wide picture of how these master transcription factors interact with the transcriptional and epigenetic 'landscape' in which they operate is still lacking 5, 6 .
So far, most mechanistic studies have used murine models, but with robust sorting and functional assays, global transcriptional analysis of human hematopoietic cell types is now feasible. An initial geneexpression analysis of 38 human hematopoietic cell subtypes identified gene modules and transcription factors circuits active in fractions enriched for stem cells and progenitor cells and reused in terminally differentiated cells 7 . One limitation of that study was the lack of highly purified immature progenitor cell and stem cell populations, which precluded delineation of the very first transcriptional events linked to commitment. Several studies have described the expression of lineage-affiliated transcriptional programs in multilineage progenitors in the mouse [8] [9] [10] . Such studies support the lineage-priming hypothesis, which argues that multipotent progenitors, before lineage restriction, have low expression of genes encoding molecules already known to be key determinants of distinct fates 11 . However, none of those studies functionally investigated whether there are additional layers of regulation upstream of the master transcription factors that affect lineage specification or alternative molecular routes for the specification of any particular fate.
At the cellular level, earlier models of hematopoietic commitment described a unique binary split between myeloid and lymphoid fates immediately downstream of a multipotent cell 12 . Several subsequent reports have challenged that view by demonstrating that lymphoid Understanding how differentiation programs originate from the gene-expression 'landscape' of hematopoietic stem cells (HSCs) is crucial for the development of new clinical therapies. We mapped the transcriptional dynamics underlying the first steps of commitment by tracking transcriptome changes in human HSCs and eight early progenitor populations. We found that transcriptional programs were extensively shared, extended across lineage-potential boundaries and were not strictly lineage affiliated. Elements of stem, lymphoid and myeloid programs were retained in multilymphoid progenitors (MLPs), which reflected a hybrid transcriptional state. By functional single cell analysis, we found that the transcription factors Bcl-11A, Sox4 and TEAD1 (TEF1) governed transcriptional networks in MLPs, which led to B cell specification. Overall, we found that integrated transcriptome approaches can be used to identify previously unknown regulators of multipotency and show additional complexity in lymphoid commitment.
npg r e s o u r c e and myeloid fates remain entangled over several early cell populations. The earliest thymic progenitors (ETPs) and granulocyte-monocyte progenitors (GMPs), long thought to be of one lineage, retain residual myeloid potential or lymphoid potential, respectively 10, 13, 14 . Notably, studies of human cord blood and bone marrow have demonstrated the existence of early-lymphoid-biased progenitors that retain myeloid potential but not erythroid potential. These progenitors, called 'multilymphoid progenitors' (MLPs) 13 or 'lymphoid-primed multipotent progenitors' 15 by analogy with the mouse system 16 , are identified as CD34 + CD38 − Thy-1 − CD45RA + cells 13, 15 or by high expression of L-selectin on CD34 + cells 17 . Given such flexibility in lymphoid commitment, it is likely that a large number of as-yet-unidentified regulators orchestrate the specification of lymphoid fate. The identification of MLPs has provided a unique opportunity with which to investigate the molecular mechanisms that underlie lymphoid-versus-myeloid lineage 'choice' in primary human hematopoietic cells.
To understand how stem, lymphoid and myeloid programs are coordinated during hematopoietic differentiation, we systematically profiled the transcriptome of MLPs in the context of nine other human HSC and progenitor-cell populations whose self-renewal and differentiation abilities are known at the single-cell level 13, 18 . At this level of cellular resolution, we identified a 'landscape' of transcriptional programs that crossed population and lineage boundaries. Computational and functional mapping of transcription factor activity in the very first stages of hematopoietic differentiation showed the molecular complexity underlying lymphoid commitment, identified additional transcription factors that contribute to B cell commitment and established that the molecular regulation of B cell specification occurs at the level of the MLP.
RESULTS

Transcriptional dynamics of early-stage human hematopoiesis
To monitor global transcriptional changes during the first steps of human hematopoietic differentiation, we prospectively isolated ten populations of cord-blood HSCs and early progenitors (hierarchical organization, Fig. 1a ; isolation, Supplementary Table 1 ). These included populations of highly enriched repopulating HSCs (HSC1, 1 in 10; HSC2, >1 in 100), transiently engrafting multipotent progenitors (MPPs) 18 and a spectrum of early committed progenitors: common myeloid progenitors (CMPs), megakaryocytic-erythroid progenitors (MEPs), GMPs and MLPs. MLPs represent the earliest lymphoid progenitors that give rise to all lymphoid lineages (B cells, T cells and natural killer (NK) cells), as well as monocytes and dendritic cells 13, 15 . Finally, we included three lymphoid-restricted precursor populations: B cell-NK cell precursors 13 ; pro-B cells; and the most primitive progenitors found in the thymus, ETPs 19 . We did geneexpression profiling with Illumina arrays with a protocol optimized for maximal sensitivity with low cell numbers.
To understand the general transcriptional 'architecture' of those ten populations, we focused on the 9,898 genes (13,385 probes) with a difference in expression of at least twofold between any populations (called 'dynamically regulated hematopoietic' (DREGH) genes here; false-discovery rate (FDR), <0.05 (one-way analysis of variance)). Principal-component analysis showed that the main lineage outcomes (stem, lymphoid, myelo-erythroid) were recapitulated in clusters of global transcriptional similarity, except for ETPs, whose transcriptome closely resembled that of myeloid progenitors ( Fig. 1b  and Supplementary Fig. 1a ). Unsupervised hierarchical clustering identified similar relationships between populations ( Supplementary  Fig. 1b ). Despite differences in the frequency of repopulating HSCs, the two stem-cell populations profiled here (HSC1 and HSC2) clustered extremely closely to each other and differed by fewer than ten genes (data not shown). We thus restricted further analyses to the HSC1 population. Finally, the gene expression of MLPs clustered much more closely with that of HSCs and MPPs than with that of more differentiated lymphoid fractions.
To capture dynamic changes in transcription during lineage commitment, we generated gene sets for precursor-product transitions, which estimate the number of genes with significantly different expression in two developmentally related populations (FDR, <0.05 (moderated t-test); Supplementary Table 2 ). We then overlaid the number of genes with different expression onto the established model of developmental relationships in the hematopoietic hierarchy 13, 18 ( Fig. 1a and Supplementary Table 3 ). Only 29 genes had different expression in HSCs versus MPPs, which indicated a very high degree of transcriptional similarity between these two cell types. The number of genes with a statistically significant difference in expression was eight times greater in the transition from MPP to CMP (7,991 genes) than in the transition from MPP to MLP (999 genes), which indicated a clear demarcation between multipotent populations (HSCs and MPPs) and progenitors committed to the myeloid lineage. Changes along the lymphoid branch of the hierarchy were more gradual, consistent with the idea that lymphoid specification is not a rapid binary 'decision' point but is instead an extended process characterized by states that are progressively more committed 20, 21 .
The establishment of a differentiated cellular identity involves the activation of lineage-specific transcriptional programs, defined as groups of genes in which expression is modulated similarly during the commitment process. To identify the dominant transcriptional programs present in the early hematopoietic hierarchy, we integrated two distinct unsupervised pattern-recognition methods, the K-means clustering algorithm and the STEM ('short-time series expression miner') algorithm 22 , which we applied to the populations most relevant to the study of lineage commitment: HSC1, MLP, pro-B cell, CMP, GMP and MEP. We clustered the DREGH genes independently with each algorithm to generate expression profiles ( Fig. 2a,b and Supplementary Fig. 1a ). Data are from one experiment with three to five independent pools of cord blood or three independent neonatal thymi (ETPs).
npg r e s o u r c e Supplementary Table 4 ). We then grouped profiles with similar kinetic and biological activity into clusters, which we defined as transcriptional programs. We named each cluster on the basis of the cell types in which the expression of the genes in that cluster was highest, which therefore related these clusters of expression profiles to meaningful biological programs and lineage-commitment routes. Both methods identified similar transcriptional programs independently of the parameters used and assigned a similar proportion of genes to each program ( Fig. 2c and Supplementary Fig. 2a ). The transcriptional program with the most genes included genes with high expression in HSCs that were downregulated in all other populations; thus, we called this the 'stem-cell program' . A reciprocal progenitor program with genes with low expression in HSCs but upregulated independently of lineage 'choice' in all other populations was the second most represented program and showed enrichment for genes encoding cell cycle-associated molecules, consistent with the higher proliferative rate of progenitors. Lineage-specific programs were less abundant; among these, lymphoid-specific clusters had more genes than did myeloid or erythroid clusters. The STEM algorithm uniquely identified a group of genes shared by MLPs and GMPs, which we called 'myelo-lymphoid'; these showed enrichment for genes encoding molecules involved in signaling via the transcription factor NF-κB, apoptosis and the immune response (data not shown). K-means clustering showed a very close association between CMPs and MEPs in their gene expression that was not otherwise detected by the STEM method. MLPs participated in four of the six main transcriptional programs ( Supplementary Fig. 2b ) and had the proliferative signature of progenitors as well as elements of both myeloid programs and lymphoid programs, consistent with their poised developmental state. Approximately 56% of the genes in the HSC cluster (as measured by the STEM algorithm; Supplementary Table 5 ) had similar expression in MLPs, despite profound differences in the self-renewal ability of these cell types. Of all the DREGH genes, 38% were transcribed similarly by HSCs and MLPs, whereas only 16-19% showed coexpression in HSCs and MEPs, GMPs or pro-B cells ( Supplementary Table 5 ), which again emphasized the transcriptional resemblance between HSCs and MLPs. Collectively, our results showed that whereas the stem, lymphoid and myeloid transcriptional programs were interwoven, the erythroid program was more separate (Supplementary Fig. 2b ). Consistent with published observations of mice 10 , we noted more gradual expression changes along the lymphoid lineage and persistent association of lymphoidand myeloid-associated genes over several steps of hematopoietic differentiation. Furthermore, the HSC program remained largely active in MLPs, which also had lymphoid and myeloid elements; this suggested that these cells most probably represent a critical stage at which lineage commitment occurs.
Transcription factor 'architecture' of lymphoid commitment Transcription factors are master regulators of lineage commitment. To capture the global complexity of the expression of transcription factors during commitment, we compiled a comprehensive list of transcription factors whose expression changed during hematopoiesis, which we 'mined' for regulators of self-renewal and differentiation. Of 1,581 putative transcriptional regulators, 477 (30%) had a significant change in expression of over twofold across the hierarchy (FDR, <0.01; Supplementary Table 6 ). The expression of the transcription factors clustered into the six main transcriptional programs described above ( Fig. 3a) , which reflected the internal structure of transcriptional changes during lineage commitment. Each transcriptional program included transcription factors shown to be important in maintaining their respective states (EVI1, ERG and Id1 in the stem cluster; GATA-1 in MEPs; the myeloid-affiliated factors C/EBP-α and PU.1 in the GMP cluster). MLPs had high expression of transcription factors that determine both myeloid cells (C/EBP-α) and lymphoid cells (IKFZ1 and EBF1), which again indicated that these cells were not fully committed to either the lymphoid fate or the myeloid fate.
To better understand transcription factor activity in MLPs and eventually identify additional regulators of lymphoid restriction, we integrated three computational approaches. First we assembled a list of transcription factors with an early-lymphoid-specific pattern of expression. This yielded 60 transcription factors whose expression was upregulated in MLPs relative to their expression on HSCs-MPPs or nonlymphoid progenitors (Fig. 3b) . Although known regulators of B cell lineage (factors of the EBF1, Id2, Fox and HOX families) and T cell lineage (Notch1, HEY1 and HES4) were in this group, most transcription factors had no known association with lymphoid development, which provided a rich resource of potential candidates whose role in lineage 'choices' will require functional confirmation. Second, to identify critical transcription factors that may not show a a b 21  3  9  8  11  10  7  13  2  4  5  12  1  6  14   9  16  49  48  31  0  18  5  1  40  23 Each box represents the mean of the expression (key below) of all genes assigned to that profile in the population in that column (below map); right margin, profile number and transcriptional program (classified on the basis of the population in which the expression of the genes in that program is highest; colors match key at right). Log-transformed expression data are mean centered and hierarchically clustered by profiles. (c) Quantitative comparison of STEM and K-means clustering, presented as the frequency of DREGH genes assigned to each transcriptional program (key); the K-means algorithm was run independently with three different values of K (8, 14 and 18) chosen after application of the adjusted 'figures of merit' method ( Supplementary Fig. 2a ) to determine at which K value the algorithm reaches its maximum predictive value. P = 0.89, STEM versus K-means for K = 14 (two-sample Kolmogorov-Smirnov test). An overlay of the transcriptional programs on the present model of hematopoietic differentiation is in Supplementary Figure 2b . Data are from one experiment.
npg r e s o u r c e difference in expression, we examined overrepresentation of known binding motifs in genes with different expression across the hierarchy. We generated population-specific gene sets for all populations (genes with the greatest difference in upregulation in one population relative to that in all other populations; Supplementary Table 7) and looked for over-representation of 385 experimentally verified or in silico-predicted cis-binding sequences of transcription factors in each gene set. We found less enrichment for motifs of transcription factor families in the myelo-erythroid gene sets (17 motifs in CMPs, GMPs and MEPs) than in the MLP and pro-B cell gene sets (33 motifs, including motifs for the Bcl-6, C/EBP-γ, CREB, STAT and Sox families; Fig. 3c ). Most families of transcription factors (11 of 17) that controlled genes with high expression in MLPs also controlled pro-B cell-specific genes, which again emphasized the complexity and gradual nature of establishing a differentiated lymphoid transcriptional program.
Finally, we sought to predict by in silico analysis how changes in the expression of particular transcription factors might account for the dynamics of gene expression that lead to the establishment of B cell identity. For this we integrated our gene-expression data with available transcription factor-binding information with the DREM ('dynamic regulatory events miner') algorithm 23 to deduce a global developmental map annotated with transcription factors most likely to control the expression changes associated with a particular transition of early B cell commitment ( Fig. 3d and Supplementary Fig. 3) .
Notably, this analysis predicted that Sox and Maf first activate genes at the transition from MLP to B cell-NK cell progenitor and then activate two distinct sets of genes in the transition to pro-B cell. It also predicted upregulation of known set of B cell genes with sites for binding to Bcl-6, Aire and Fox in the transition from MLP and B cell-NK cell progenitor; a series of genes encoding apoptosis-related molecules that are repressed in pro-B cells also had similar binding sites. Collectively, this integrative bioinformatics approach identified previously unknown transcription factors anticipated to control B cell specification and predicted that these factors may serve complex roles by controlling distinct sets of genes at different stages of lineage specification.
Identification of early regulators of commitment in MLPs
Our bioinformatics analysis predicted that lineage-specific transcriptional networks were not yet stabilized in MLPs. To test that idea and to identify key determinants of lymphoid-versus-myeloid commitment, we perturbed lineage outcomes by silencing key transcription factors in MLPs. Given the computational analysis of MLP-specific transcription factors, we studied the function of factors with DNAbinding motifs that were over-represented in the MLP-specific gene set ( Fig. 3c ) or that were predicted in silico to act recurrently during B cell development ( Fig. 3d) , as these most likely represented key nodes in the MLP regulatory circuit (bold, Fig. 3b ). We verified the expression of these candidates across the hematopoietic hierarchy by quantitative RT-PCR ( Supplementary Fig. 4a ). To examine the role of these transcription factors in lymphoid development, we developed lentiviral vectors that expressed short hairpin RNA (shRNA) that efficiently silenced the expression of eight of twelve candidate transcription factors (Supplementary Fig. 4b,c ) and assessed the Supplementary Table 7) ; bold indicates families for which at least one member was among the 60 early-lymphoid-specific transcription factors, as defined by their expression. (d) Dynamic regulatory map of transcription factors that control specification to B cells, generated with the DREM algorithm and plotted as log-transformed expression relative to that of the first developmental stage (HSC) and stepwise progression along B cell commitment; lines indicate average expression of a group of genes (circle size, s.d.), and labels adjacent indicate transcription factor families predicted to be stage-specific regulators of expression also found in b,c (complete output, Supplementary Fig. 2 ). Data are from one experiment. 
npg r e s o u r c e clonal potential of sorted single MLPs to differentiate into monocytic cells, B cells and NK cells in vitro. We depleted cord blood of lineage marker-positive cells, then transduced the resultant cells with shRNAexpressing lentiviral vectors and sorted single MLPs into plates seeded with MS-5 mouse stromal cells 24 in the presence of the appropriate cytokines ( Supplementary Fig. 4d ). After 3 weeks, we quantified transduced (green fluorescent protein-positive (GFP + )) myeloid, B cell and NK cell colonies by detection of lineage-specific cell-surface markers (Supplementary Fig. 4e ). We extensively confirmed the ability of this MS-5 cell-myeloid cell-B cell-NK cell assay to accurately identify changes in lineage commitment (Supplementary Note 1 and Supplementary Fig. 4f-h) . In particular, silencing of EBF1, which encodes a key master regulator of B cell specification, by shRNA resulted in the formation of significantly fewer B cell colonies in our assay. Silencing of GATA2, which is not expressed in MLPs, by shRNA did not affect any of the developmental outcomes of MLPs (Fig. 4a) . We next determined whether silencing of genes encoding eight candidate transcription factors altered the lineage outcomes of MLPs by screening over 8,500 single cell-derived colonies. Our screen identified four transcription factors (Bcl-11A, Sox4, Bcl-6 and TEAD1) with a significant effect on lymphoid colony formation in multiple independent experiments (Fig. 4b) . Of note, the results described below were recapitulated with independent shRNA constructs ( Fig. 4b) , except for results obtained for silencing of BCL6, for which we were unable to generate a second shRNA construct that resulted in a significantly lower abundance of BCL6 mRNA. Thus, we cannot exclude the possibility of potential off-target effects in the BCL6-silencing phenotypes described below. Silencing of SOX4 or BCL6 led to significantly fewer B cell and NK cell colonies. Also, cultures of cells in which BCL6 or SOX4 was silenced by shRNA contained proportionally more fully differentiated monocytic colonies than did cultures obtained with control shRNA, as judged by the number of CD14 + colonies (Fig. 4c) . These observations suggested that Bcl-6 and Sox4 acted in MLPs or their immediate progeny to promote lymphoid differentiation while repressing myeloid fates. Silencing of BCL11A or TEAD1 generated fewer B cell colonies (Fig. 4b) , but MLPs differentiated normally into NK cells and myeloid cells. These data suggested that Bcl-11A and TEAD1 acted in B cell development at or downstream of B cell specification. We observed no significant difference in the proportion of cycling cells (Fig. 4d ) or apoptotic cells (data not shown) in MLPs after a week of culture on MS-5 stroma, which suggested that the skewed colony distributions derived from an alteration in commitment 'decisions' . In addition, these transcription factors specifically governed the lympho-myeloid lineage 'choice' , as we observed no skewing of myelo-erythroid output in conventional colony-forming assays after silencing of BCL11A, SOX4, BCL6 or TEAD1 by shRNA in CD34 + cells (Fig. 4e) . In summary, our functional confirmation of transcription factors predicted to be important regulators by a global computational analysis of human cord blood progenitors identified overlapping and distinct roles for Bcl-11A, SOX4, Bcl-6, and TEAD1 in human lymphoid development.
Bcl-11A, Sox4 and TEAD1 regulate B cell commitment During B lymphopoiesis, precursors of B cells transit through a continuum in which alternative fates are progressively repressed and B cell identity is gradually acquired 21 . To precisely establish at which developmental stage the four transcription factors identified in the screen above influence B cell differentiation, we reconstituted human hematopoiesis in xenografts in which all steps of human B cell commitment are recapitulated 25 . We depleted cord blood of lineage marker-positive cells and transduced the resultant cells with lentiviral vectors expressing shRNA targeting BCL11A, BCL6, SOX4 or TEAD1, then injected transduced HSC-enriched (GFP + CD34 + ) Figure 4 Single-cell shRNA-based silencing screen for transcription factors that determine commitment of MLPs to the lymphoid fate. (a,b) Proportion of myeloid (CD11b + ) colonies (top), lymphoid (CD19 + ) colonies (middle) and NK cell (CD56 + ) colonies (bottom) generated from each single MLP with silencing of transcription factors by shRNA (sh) targeting EBF1 or GATA2 (a) or BCL11A, SOX4 or TEAD1 (two constructs for each, -1 and -2), BCL6, IRF8, MAF, RUNX2 or TSC22D1 (b), normalized to that generated from a single MLP from the same pool of cord blood transduced with lentiviral vector expressing control shRNA (targeting the gene encoding β-galactosidase (lacZ) or luciferase (called 'LUC ' here). Non-normalized data, Supplementary Table 8 . Fig. 5a ). Normal percentages of total B cells (CD19 + ) were produced in mice given transplantation of cells in which BCL6 was silenced (Fig. 5a) . In contrast, mice given transplantation of cells in which BCL11A, SOX4 or TEAD1 was silenced had a significantly lower frequency of total B cells than did mice given transplantation of cells transduced with control shRNA ( Fig. 5a and Supplementary Fig. 5b,c) , which confirmed our in vitro results. We then analyzed production of the various developmental intermediates of B cell differentiation (Supplementary Fig. 5d ). Mice given transplantation of cells in which BCL6 was silenced had fewer MLPs than did mice given transplantation of cells transduced with control shRNA (Fig. 5b) ; those MLPs were nonetheless directed along the B cell-differentiation path, as they gave rise to almost normal numbers of early B cells (Supplementary Fig. 5e ). In contrast, silencing of BCL11A or SOX4 resulted in a significantly greater proportion of MLPs than did transduction of control shRNA; we observed a similar trend after silencing of TEAD1 (Fig. 5b) , which suggested a differentiation block at this stage. Quantification of population doublings at each step downstream of MLPs showed that the progression from MLP to early B cell was significantly compromised after silencing of BCL11A, SOX4 or TEAD1 (Fig. 5c) . We observed no change in proliferation or apoptosis in early B cells in which BCL11A or SOX4 was silenced ( Fig. 6a,b) , which indicated that the observed lower abundance of B cells was due to an early differentiation defect. Of note, after silencing of TEAD1, the transition from early B cell to pro-B cell was also significantly compromised ( Fig. 5c) , which led to less than 25% as many pro-B cells than those generated after transduction of control shRNA (Supplementary Fig. 5e,f) ; this could be explained by a trend toward more apoptosis in the early B cell compartment (Fig. 6a) . The few pro-B cells in which TEAD1 was silenced that were produced cycled much more than did their counterparts transduced with control shRNA (P < 0.1, Supplementary Fig. 6a ) and generated a nearly normal abundance of pre-B cells ( Supplementary  Fig. 5e ). We observed no such changes in proliferation for pro-B cells and pre-B cells in which BCL11A or SOX4 was silenced by shRNA ( Supplementary Fig. 6a,b) . These findings raised the possibility that Bcl-11A, Sox4 and TEAD1 might act upstream of some of the master regulators of B cell commitment. We therefore examined by quantitative RT-PCR whether lower expression of BCL11A, SOX4 or TEAD1 affected the expression of IKZF1, E2A, EBF1 and PAX5 in early B cells and found that all three genes altered the expression at least one of those four genes, which encode transcription factors necessary for lymphoid development (Fig. 6c) Supplementary  Fig. 5a ), analyzed 8-10 weeks after transplantation (raw data, Supplementary  Table 9 ; results for other bones, Supplementary Fig. 5b,c) . Each symbol represents an individual mouse (n = 21 (shlacZ), 19 (shBCL11A), 23 (shLUC), 5 (shBCL6), 12 (shSOX4) or 14 (shTEAD1); boxes outline the first and third quartiles (horizontal lines, median and s.e.m.). *P < 0.0001 and **P < 0.0002 (unpaired two-tailed t-test). (b) Frequency of MLPs among human (GFP + ) cells in the xenografts in a (gating strategy, Supplementary  Fig. 5d ): n = 4 mice (shlacZ and shBCL11A), 18 mice (shLUC), 5 mice (shBCL6) or 12 mice (shSOX4 and shTEAD1). *P < 0.1 and **P < 0.05 (unpaired two-tailed t-test). (c) Population doubling between various populations (below) in the xenografts in a (gating strategy, Supplementary  Fig. 5d ), calculated as log 2 (product population / precursor population) (full quantification, Supplementary Fig. 5f) . Fig. 6c ).
DISCUSSION
Here we have delineated the gene expression of highly purified and functionally defined human HSCs and progenitors, providing a resource for investigation of the earliest steps of human hematopoietic differentiation. Our bioinformatics analysis showed a 'landscape' of tightly interconnected transcriptional programs that contrasted with many commonly accepted predictions of a rigid demarcation of stemcell and lineage-commitment circuits. Through a combined computational and functional approach, we have shown considerable molecular complexity in lymphoid commitment and have identified Bcl-11A, Sox4 and TEAD1 as additional lymphoid transcription factors that act upstream of known master regulators of B cell commitment. Several principles underlying loss of stemness and lineage commitment have emerged from our analysis of global patterns of gene expression. First, transcriptional programs were shared among cell types with similar lineage potential (MLPs and pro-B cells; CMPs and MEPs; and MLPs and GMPs, both monocyte precursors). Second, transcriptional programs crossed physiological lineage boundaries. For example, GMPs, which give rise to myeloid cells, and ETPs, which generate T cells in the thymus, also had very similar transcription profiles. Such similarity is not unexpected given the myeloid potential of ETPs 14 and the ability of GMPs to produce T cells when stimulated appropriately 10, 13 . A third important principle is that the HSC programs did not terminate abruptly but persisted for many stages. HSCs and transiently repopulating MPPs differed only by a handful of genes in our analyses, which raised the possibility that the predominant regulation of self-renewal does not occur at the transcriptional level. This conclusion remains tentative, as the limitations of microarray technology may not allow it to capture subtle but important transcriptional differences. The stem-cell program was also partially carried over into MLPs, which continued to express many but not all HSC genes. That phenomenon can be interpreted in terms of the lineage-priming hypothesis, which postulates that genes important for differentiation into a particular fate already have low expression in HSCs. However, the expression of many genes, including some encoding molecules with established stem-cell functions (such as EVI1, ERG and Id1), was maintained at similar or slightly lower amounts in MLPs, which indicated that MLPs retained components of the stem-cell 'circuitry' . A fourth principle was that MLPs did not have a unique transcriptional program but instead had partially established stem, myeloid and lymphoid transcriptional programs. Thus, we propose that the molecular regulation of the acquisition of a myeloid or lymphoid fate occurs physiologically at the level of the MLP.
The computational description of the transcriptional programs and transcription factor 'architecture' presented here suggests a model in which lymphoid specification proceeds more gradually and involves more molecular participants than does commitment to the myeloid fate. If potential functions of epigenetic regulators and microRNAs not analyzed here are taken into account, our results, together with published results 7, 26 , indicate that the molecular circuitry underlying the entry into B cell specification is probably more complex than previously assumed. Given the present view of hematopoiesis 20 , in which there is no early obligatory separation between myeloid and lymphoid fates, it seems likely that myeloid differentiation is a default commitment program that needs to be shut down for other lineages to be specified 27 . Accordingly, in the thymus, T cell specification requires downregulation of genes expressed in progenitor cells of distinct lineages, which is achieved through multiple distinct repressor functions 28 . Likewise, we propose the existence, in B cell commitment, of an additional layer of regulation by transcription factors, composed of molecules such as Bcl-11A, Sox4, TEAD1 and IKZF1 (ref. 10) , that sets the stage for activation of the self-sustaining EBF1-Pax5 axis 29 , which is itself required and sufficient for the establishment of the full B cell-differentiation program. We speculate that such molecular organization makes the entry into B cell specification more adaptable to shifting demands.
Three of the transcription factors for which we have described a role in the very early stages of lymphoid commitment have been linked to later steps of lymphopoiesis. Bcl-6 has key roles in germinal center B cells 30 and is required for the formation of a diverse B cell repertoire 31 . Our results obtained with a single shRNA targeting BCL6 should be interpreted with caution, but they suggest that Bcl-6 is also active during much earlier stages of hematopoiesis by regulating the formation or differentiation of MLPs. Our data obtained by silencing of BCL11A or SOX4 are consistent with the phenotype of mice deficient in Bcl-11A or Sox4, in which there is no B cell development 32-34 , but we have further shown that these transcription factors directed MLP commitment to the B cell lineage rather than limiting later differentiation steps. The fourth transcription factor identified, TEAD1, has not been associated with hematopoiesis before, to our knowledge. TEAD1 functions with the transcription coactivator YAP downstream of the Hippo tumor-suppressor pathway 35 . YAP overexpression in the mouse does not alter the self-renewal or differentiation of HSCs 36 . Thus, by showing that TEAD1 first activated MLPs to early B cell progression and also favored transition to the pro-B cell stage, we have provided evidence that the Hippo pathway functions in lymphopoiesis.
The data presented here represent a resource with which to identify cell type-specific gene-regulatory networks, which when integrated with future high-throughput RNA sequencing, genome-wide analysis of chromatin occupancy and analyses of epigenetic modification will shed further light on how hematopoietic cells are driven to commitment. We make available stem cell-and progenitor cell-specific gene-expression data sets as well as transcriptional program signatures that will, among other uses, facilitate the classification of tumor subtypes on the basis of their transcriptional homology to normal progenitor cells 37, 38 and provide information about their cell of origin. In addition, our data will contribute to improved methods for the hematopoietic differentiation of pluripotent stem cells by serving as a molecular 'road map' with which to compare engineered cell types with their normal counterparts. Finally, the principle of obligatory sharing of transcriptional programs in the first steps of differentiation identified here could be a general design principle conserved in other stem cell-driven tissues.
METHODS
Methods and any associated references are available in the online version of the paper. Isolation of cell populations for gene expression profiling. Lin − cells were thawed and then were stained (at a density of 1 × 10 6 cells per 100 µl) with the following antibodies (all from BD, unless stated otherwise): fluorescein isothiocyanate-anti-CD45RA (1:25; 555488), phycoerythrinanti-CD90 (1:50; 555596), phycoerythrin-anti-CD135 (1:10; 558996), phycoerythrin-indodicarbocyanine-anti- CD49f (1:100; 551129) , phycoerythrin-indodicarbocyanine-anti-CD7 (1:100; PNIM3613U; Beckman Coulter), phycoerythrin-indotricarbocyanine-anti-CD38 (1:100; 335790), allophycocyanin-anti-CD10 (1:25; 340923), allophycocyaninindotricarbocyanine-anti-CD34 (1:100; custom-made by BD). Cells were sorted into low-binding 1.5-ml tubes (Axygen) with a FACSAria (BD) to a purity of >95%. Freshly sorted populations of progenitor cells were pelleted and resuspended in TRIzol (Invitrogen).
Microarray mRNA profiling and data preprocessing. RNA extraction, cDNA synthesis and preamplification were done as described 39 . Whole-genome gene-expression analysis was done with the human Whole-Genome DASL HT-12 Assay (version 4.0) R2 (Illumina), which investigates ~29,000 targets (corresponding to ~21,000 genes) 40 .
Bioinformatics analysis.
If not specified otherwise, software of the R project for statistical computing (version 2.12.1) and Bioconductor (version 2.10) were used for all bioinformatics analyses. The 'cor' and 'hclust' functions of R software were used for Pearson's correlations and hierarchical clustering. For principal-component analysis (PCA), eigenvalues from PCA of real data were first compared with PCA of randomized data to evaluate which components were the most relevant (Supplementary Fig. 1a ) and then the 'dudi.pca' function of the Ade4 package of R software (version 1.4-16) was used. Hierarchical clustering and PCA based on the Pearson correlation coefficient of all samples, as well as the percentage of presence 'calls' (P detection values of <0.05) for each sample were used for quality control. Data were quantile-normalized ('normalizeQuantiles' command of limma software (Linear Models for Microarray Data; version 3.6.9), then were log 2transformed. All subsequent analyses used this data set.
The DREGH list was generated with GeneSpringGX software (Agilent), with one-way analysis of variance of all ten populations profiled in this study, with the Tukey HSD post-hoc test and Benjamini-Hochberg multipletesting correction. Genes with a multiple-test adjusted P value of <0.05 and an absolute change in expression of over twofold (13, 385 probes, which corresponded to 9,898 genes) were used for further analysis. All other tests of differences in expression were done with the limma package (version 3.6.9), which calculates the moderated t-test statistic for a particular contrast. All t-test scores were controlled for multiple-hypothesis testing with the Benjamini-Hochberg method. Unless otherwise stated, genes were considered to have a difference in expression with an adjusted P value of <0.05. Three main group of contrasts were generated: population-specific gene sets in which the mean expression of a gene in a particular population (such as MLP) was compared with the mean expression in all other populations; transcriptional program gene sets, in which the samples contrasts were chosen to best reflect the transcriptional programs identified by undirected pattern discovery; and precursor-product transitions gene sets, for which the expression of each gene in a particular population (such as B cell-NK cell precursor) was compared with its expression in the closest known progenitor population (such as MLP) independently of all other samples (summary of all such lists, Supplementary Table 2 ).
Derivation of transcriptional programs. The STEM algorithm 22 was obtained from the website of the Systems Biology Group of the School of Computer Science of Carnegie Mellon University (http://gene.ml.cmu.edu/stem/). This clustering method first defines a set of representative model profiles that correspond to possible patterns of gene expression across the conditions analyzed in the experiment. On the basis of correlation coefficients, each gene is assigned to the closest profile in terms of expression. The number of genes expected randomly for each profile is also computed (random permutation of original values for each gene, renormalization then assignment to profiles, repeated over 500 permutations) and serves as a basis for the calculation of the statistical significance of each profile. Statistically significant profiles represent the dominant expression profiles in the data set. By the STEM method, the number of profiles is thus unbiased, as it is determined by the algorithm and not by the user. The parameters used for STEM clustering were set at a maximum of 50 model profiles, a maximum unit change between time points of 1 and a minimum correlation for clustering similar profiles >0.5. For geneontology enrichment with this program, P values were corrected with 500 randomizations and were considered significant with an FDR of <0.05. As the STEM algorithm was first implemented for analysis of temporal expression profiles, the analysis was done with three different population orders, which all yielded similar results. K-means clustering was done with R software with the function 'kmeans' setting number of clusters K to 8, 10 or 14. To determine these values of K, objectives values, we used the 'figures of merit' method 41 (implemented in MultiExperiment Viewer software).
Both algorithms produced many 'profiles' (predefined for K-means, but automatically (unbiased) calculated by STEM on the basis of the data set). As pattern-recognition methods will find profiles that, even though they are distinct in intensity of expression, represent the same kinetic or biological activity, similar 'profiles' (based on correlation coefficient) were then grouped into clusters, which were effectively our 'transcriptional programs' . This was done independently for STEM or K-means run with different parameters. Each cluster was named for the cell types in which the expression of the genes in that cluster was the highest, which related the clusters of expression profiles to meaningful biological programs.
To quantify the degree of similarity between HSCs and progenitor populations of distinct lineages, we first calculated the median s.d. value for the expression of all DREGH genes among HSC biological replicates. We then considered that a particular gene had similar expression in HSCs and a more differentiated population (MLPs, GMPs, MEPs or pro-B cells) if its expression in the latter was within one s.d. from its value in HSCs.
Pathway-enrichment analysis. The likelihood of over-representation of gene-ontology categories in particular gene lists was estimated with the Explain software suite from Biobase, which is derived from a hypergeometric distribution.
Analysis of transcription factor 'architecture' . The list of transcription factor or regulators of transcription was annotated by aggregation of geneontology and Kyoto Encyclopedia of Genes and Genomes categories containing 'transcription factor' or 'transcription regulator activity' , which yielded 1,581 genes, 477 of which had a difference in expression of over twofold with an FDR of <0.01 by one-way analysis of variance analysis with the Tukey HSD post-hoc test and Benjamini-Hochberg multiple testing correction (GeneSpringGX software; Agilent). Supplementary Table 2 were selected to generate a method for assigning scores to transcription factors with an early lymphoid pattern of expression (numbers in parentheses correspond to list number in Supplementary Table 2) : an MLP-specific gene set (2) ; genes coexpressed in HSCs and MLPs (8) ; the gene set of the HSC-to-MLP transition (14) ; the gene set of the MLP-to-pro-B cell transition (19) ; and the MLP and GMP comparison (24) . Each list was restricted to transcription factors with an FDR of <0.05 and absolute difference in expression of over twofold and was then ranked by difference in expression. Rank position scores (RPS) were assigned, with the transcription factors with the greatest upregulation given a score of +1 and those with the greatest downregulation given a score of −1. For every list, the number of transcription factors with significant upregulation and downregulation were designated n UP and n DOWN , respectively. There were 452 total unique transcription factors in npg the five lists. For each of those, an overall lymphoid score (λ) was calculated as the harmonic sum of renormalized ranks, as follows: 
Assembly of a list of transcription factors with an early-lymphoid-specific pattern of expression. Five lists of genes with a difference in expression from
This strategy gave more weight to the genes with the greatest difference in expression in any list. Transcription factors with negative overall lymphoid scores, as well as transcription factors with higher expression in HSCs than in MLPs, were eliminated. As the initial transcription factor list contained many transcriptional regulators that are not actually transcription factors, the latter were manually discarded, which resulted in the 60 transcription factors studied (Fig. 3b) . This list included known regulators of the development of B cells (the EBF1, Id2, Fox and HOX families), T cells (Notch1, HEY1, HES4) and myeloid cells (Runx1). Specific factors (bold, Fig. 3b ) were selected for further functional confirmation because they were also predicted to bind to the promoters of genes either with high expression in MLPs (Fig. 3c) or dynamically regulated during B cell development (Fig. 3d) .
Enrichment for transcription factor-binding motifs. Analysis of enrichment for transcription-binding motifs was done independently for each of the eight population-specific gene sets (Supplementary Table 2 ). Each of these was restricted to genes upregulated in a certain population (such as MLPs) with a FDR of <0.05, a log 2 average expression of >7 and a cutoff for the difference in expression that resulted in gene lists ranging from 300 to 1,000 genes ( Supplementary Table 7 ). Explain3.0 software from Biobase was used to determine which transcription factors most probably control the genes in each data set. The software makes use of the following two databases: TRANSFAC (experimentally confirmed transcription factor-binding sites and their target genes) and TRANSPRO (vertebrate promoter sequences annotated with their characteristics). Two independent algorithms, F-MATCH 42 and P-MATCH 43 were used to find transcription factor-binding sites and compare the number of sites found in these query sequences against that of a background gene set. A restricted version of the DREGH list (5,658 genes) was chosen as a background set, as with an annotated list of housekeeping genes which promoters are GC rich led to false-positive over-representation of AT-rich matrices in all the population-specific gene sets here. Furthermore, we hypothesized that the use of a set of 'pan-hematopoietic' genes as background would enhance the detection of population-specific transcription factor families. Promoters were scanned for the presence of motifs in a window spanning 500 base pairs upstream and 100 base pairs downstream of the transcription start site. After search, matrix cutoffs and window positions were optimized. Only the promoters of the TRANSPro database with the best support were used. P value cutoffs of 0.01 and 0.05 were used for F-MATCH and P-MATCH, respectively. Only transcription-factor families with significant enrichment by both algorithms were retained. An enrichment score (ES) was calculated for each of these on the basis of the geometric mean of the negative logarithms of the F-MATCH and P-MATCH values as follows: Transcription factor-annotated regulatory event map along B cell commitment. An annotated 'pan-hematopoietic' transcription factor-target interaction database was generated with a search for all known predicted and known transcription factor-binding sites in the promoters of DREGH genes. ExPlain3.0 data-analysis software (Biobase) was used to run the F-MATCH algorithm without any background set, with the whole collection (13,957) of experimentally verified and predicted transcription factor-binding sites and positional weight matrices of the TRANSPRO database. Of the 9,898 genes in the DREGH gene list, 9,523 had annotated promoters in the TRANSPRO database. We also incorporated transcription factor-target interactions derived from data sets obtained by chromatin immunoprecipitation followed by microarray analysis 44, 45 . This information was collapsed into a matrix containing 466,453 transcription factor-target interactions. To simplify model building with DREM software (described below), the transcription factor-target interactions database was restricted to 255,843 entries corresponding to the transcription factor families that were found to be enriched in the promoters of at least one of our population-specific gene sets. DREM software 23 from the website of the Systems Biology Group of the School of Computer Science of Carnegie Mellon University (http://gene. ml.cmu.edu/drem/) was used to build a regulatory event map. The expression data input contained log 2 -transformed signal data from the DREGH gene list, restricted to data sets of HSCs, MLPs, early B cell and pro-B cells, in that order, which reflects progression along B cell commitment. All signals were normalized to the first time point, the HSC. Genes were kept in the analysis even in the absence of transcription factor input data. The minimum absolute difference in expression between time points was set to 1.4-fold. The model was built with the transcription factor-gene interaction data together with the expression data to produce a more biologically coherent model. A maximum of three paths from a split event was enforced and no path merging was allowed. Transcription factors associated with nodes or splits with a score of <0.01 based on the hypergeometric distribution were considered in the analysis. Of note, as the transcription factor data were used to 'learn' the model, the score does not represent a true P value, but the lower the score, the more significant the association. Gene-ontology annotation was run in DREM software with an FDR of <0.01 (with the Bonferroni correction).
Lentiviral vector constructs and transduction.
All shRNA sequences used in this study were derived from the TRC library of the Public TRC Portal (RNAi Consortium, Broad Institute) and were synthesized as oligonucleotides phosphorylated at the 5′ end and were cloned into pLKO vectors 46 in which the puromycin-resistance cassette was replaced by sequence encoding GFP. Hairpins were placed under control of the promoter of the gene encoding ribonuclease P component H1 (shRNA targeting BCL11A, IRF8, MAF, RUNX12, TSC22D1 or LacZ) or the U6 small nuclear RNA core promoter (shRNA targeting BCL6, EBF1, GATA2, SOX4, TEAD1 or the gene encoding luciferase). Viral particles were produced as described 47 and were 'titrated' on 293T human embryonic kidney cells. For transduction, Lin − cord blood cells were thawed and then incubated for 3-5 h at 37 °C in X-VIVO 10 medium (BioWhittaker) supplemented with 1% BSA and the following cytokines (all from R&D Systems): stem cell factor (100 ng/ml), the ligand Flt3L (100 ng/ml), thrombopoietin (50 ng/ml) and interleukin 7 (IL-7; 10 ng/ml). Cells were then incubated for 16 h (MS-5-myeloid cell-B cell-NK cell (MS5-MBN) assay) to 24 h (in vivo assays) in the same medium supplemented with virus at a multiplicity of infection of 50-130 transforming units per ml.
MS5-MBN assay. MS-5 stromal cells 24 (4 × 10 5 to 5 × 10 5 ) were seeded in 96-well plates (Nunc) coated with 0.2% gelatin (Sigma), in H5100 medium (Stem Cell Technologies) supplemented with penicillin-streptomycin, l-glutamine and the following cytokines (all from R&D Systems): stem cell factor (100 ng/ml), Flt3L (10 ng/ml), thrombopoietin (50 ng/ml), IL-2 (10 ng/ml), IL-7 (20 ng/ml), IL-6 (20 ng/ml), granulocyte colony-stimulating factor (20 ng/ml) and granulocyte-macrophage colony-stimulating factor (20 ng/ml). Then, 48 h later (12 h after transduction), transduced Lin − cells were washed, and one or two MLP cells were sorted onto the stroma. Half of the medium was changed weekly and, 3 weeks after cell seeding, colonies were collected, resuspended by physical dissociation and filtered through 96-well filter plates (Pall Life Sciences) and the entire content of each well was screened by flow cytometry. Myeloid cell colonies were defined as CD56 − CD11b + whether they were CD14 + (monocytic) or CD14 − (non-monocytic). B cell colonies were identified as CD11b − CD19 + cells, whereas NK cell colonies were
